Assessing AI-Based Decision Support in Early Sepsis and AKI Recognition
Clinical Snapshot
PICO Framework
| P — Population | Patients at University Hospital Augsburg requiring sepsis and acute kidney injury risk assessment |
| I — Intervention | AI-based Clinical Decision Support System (CDSS) for real-time risk predictions |
| C — Comparator | Standard clinical practice without AI-based CDSS (pre-implementation period) |
| O — Outcomes | Diagnostic accuracy for early sepsis and AKI recognition, patient safety outcomes |
Bottom Line
This retrospective cohort study evaluates an AI-based clinical decision support system for early sepsis and AKI recognition at a German university hospital. While addressing clinically important conditions, the abstract provides insufficient methodological detail for proper critical appraisal. The before-after implementation design is appropriate for evaluating real-world effectiveness but carries inherent risks of temporal confounding. Key limitations include single-centre design, unclear patient selection criteria, and absence of quantitative results. The study's relevance to Australian practice would depend on regulatory approval and local validation of similar systems. Clinicians should await full publication with detailed methodology and results before considering clinical application. The 50% CEBM score reflects the limited information available for assessment rather than study quality.
Key Findings
P Value: Not reported
Effect Size: Not reported in abstract
Primary Outcome: Diagnostic accuracy for sepsis and AKI recognition
Nnt Or Sensitivity: Sensitivity and specificity metrics not provided
Confidence Interval: Not reported
Clinical Application
Implementation requires significant IT infrastructure and clinical workflow integration Relevance to Australian hospitals depends on TGA approval of similar CDSS systems and integration with existing electronic medical records. Would need evaluation within Australian clinical governance frameworks Hospitalised patients at risk of sepsis and acute kidney injury in acute care settings
Abstract
Sepsis and acute kidney injury (AKI) remain among the most critical conditions in acute care, associated with high morbidity and mortality. Early risk recognition is essential but often hampered by nonspecific symptoms. Recent studies have demonstrated that AI- and ML-based Clinical Decision Support Systems (CDSS) can enhance the early detection of sepsis and AKI and support clinical decision-making [1-3]. In May 2025, the University Hospital Augsburg (UKA) integrated an externally developed AI-based CDSS to provide real-time risk predictions for sepsis and AKI. This study evaluates the effectiveness of the system in routine clinical practice using retrospective data from periods before and after its implementation. Primary endpoints include diagnostic accuracy. The results will indicate whether the CDSS contributes to improved early risk recognition and enhanced patient safety in a real-world hospital environment.
References
- 1.Ortmann, N., Mergenthaler, M., Soto-Rey, I., & Hinske, L. C. (2026). Assessing AI-Based Decision Support in Early Sepsis and AKI Recognition. Studies in Health Technology and Informatics. https://doi.org/10.3233/SHTI260214
Related Research
Journal of the American Medical Informatics Association : JAMIA
Explainable machine learning in healthcare: methods, interpretation, and applications for clinical research
2 Aug 2026
Neurosurgical review
Development and external validation of a machine learning model for predicting postoperative hydrocephalus in 1,073 posterior fossa tumor patients
31 July 2026
JAMA
Prone Positioning in Infants With Acute Bronchiolitis: The PROPOSITIS Randomized Clinical Trial
30 July 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service